Trinity Biotech plc announced the appointment of Louise Tallon as Chief Financial Officer (CFO). Louise will join Trinity Biotech in August 2024. Des Fitzgerald, who has acted as interim CFO since December 2023 will continue as interim CFO until late July 2024.

Louise is currently Head of Group Finance at Inizio, a leading global commercialisation partner in pharmaceuticals. Prior to this, she had a 16-year career with UDG Healthcare plc, where she held a number of senior finance roles of increasing responsibility. Over her 19-year career in the life sciences industry, as a transformative leader, Louise has been at the forefront of adapting and evolving finance functions in a rapidly changing business landscape.

Louise trained as an accountant in KPMG, having received a BBS, Finance, Economics and Business in Trinity College Dublin.